Literature DB >> 10163326

The toxicology of mitomycin C on the ciliary body.

H Mietz1.   

Abstract

Over the past few years, the use of mitomycin C (MMC) to reduce surgical failures following filtering procedures has largely increased. After topical application, significant amounts of MMC can be detected intraocularly. In both rabbit and human eyes, a reduction of the normal and elevated intraocular pressures could be achieved with subconjunctival injections of MMC without filtering procedures. Histopathologic examination of the ciliary body in a human eye shortly after surgery with MMC revealed moderate, diffuse toxic changes of the two layers of the ciliary epithelium. By fluorophotometry, eyes after trabeculectomy with MMC had a decreased production of aqueous humor compared with eyes that underwent trabeculectomies without antimetabolites. Independent studies suggest that the toxicity of MMC for the ciliary epithelium may be a significant factor contributing to postoperative hypotony.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 10163326     DOI: 10.1097/00055735-199604000-00013

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  8 in total

1.  Aberrant wound-healing response in mitomycin C-treated leaking blebs: a histopathologic study.

Authors:  Victor M Elner; Paula Anne Newman-Casey; A Jayaprakash Patil; Andrew Flint; Jyotirmay Biswas; Sayoko E Moroi; Vaijayanthi Pushparaj; Deepak P Edward
Journal:  Arch Ophthalmol       Date:  2009-08

2.  Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks.

Authors:  N Anand; S Arora; M Clowes
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

3.  Photodynamic modulation of wound healing in glaucoma filtration surgery.

Authors:  J F Jordan; M Diestelhorst; S Grisanti; G K Krieglstein
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

4.  Long-term outcomes of needle revision of failing deep sclerectomy blebs.

Authors:  Antigoni Koukkoulli; Fayyaz Musa; Nitin Anand
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-10-11       Impact factor: 3.117

5.  Bimatoprost-induced late-onset choroidal detachment after trabeculectomy: A case report and review of the literature.

Authors:  Shunsuke Nakakura; Asuka Noguchi; Hitoshi Tabuchi; Yoshiaki Kiuchi
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

Review 6.  Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma.

Authors:  Vanessa Andrés-Guerrero; Lucía Perucho-González; Julián García-Feijoo; Laura Morales-Fernández; Federico Saenz-Francés; Rocío Herrero-Vanrell; Luis Pablo Júlvez; Vicente Polo Llorens; José María Martínez-de-la-Casa; Anastasios-Georgios Konstas
Journal:  Adv Ther       Date:  2016-12-20       Impact factor: 3.845

7.  Choroidal Detachment after XEN Gel Stent Implantation.

Authors:  Carlo Alberto Cutolo; Letizia Negri; Sara Olivari; Francesca Cappelli; Carlo Enrico Traverso; Michele Iester
Journal:  J Ophthalmol       Date:  2021-03-06       Impact factor: 1.909

8.  Comparative study between trabeculectomy with photodynamic therapy (BCECF-AM) and trabeculectomy with antimetabolite (MMC) in the treatment of primary open angle glaucoma.

Authors:  Ahmed M Saeed
Journal:  Clin Ophthalmol       Date:  2012-10-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.